FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely to clinical allergology, and may be used for extracorporeal allergen denaturation. That is ensured by treating a surface of objects with an allergen-denaturing composition. The composition contains calcium chloride or calcium acetate and lanthanum chloride or lanthanum nitrate in certain proportions.
EFFECT: combinations of the above metal salts selected in certain proportions provide the effective allergen denaturation ex vivo by a synergistic denaturation action of the given ingredients.
9 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING ALLERGEN EXTRACT | 2011 |
|
RU2706685C2 |
| HYPOALLERGIC FUSED PROTEIN, NUCLEIC ACID MOLECULE CODING IT, EXPRESSION VECTOR, HOST CELL, VACCINE COMPOSITION, AND USE THEREOF | 2007 |
|
RU2486206C2 |
| METHOD OF OBTAINING ALLERGEN EXTRACT | 2011 |
|
RU2572230C2 |
| METHOD FOR RELIEVING ALLERGIC REACTIONS CAUSED BY AMBIENT ALLERGENS | 2008 |
|
RU2491937C2 |
| HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
| COMPOSITIONS AND METHODS FOR REDUCING FELINE ALLERGENS IN ENVIRONMENT | 2014 |
|
RU2706206C1 |
| PHARMACEUTICAL PRODUCT CONTAINING MITE ALLERGEN EXTRACT(S) AND METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2711727C1 |
| PHARMACEUTICAL PRODUCT CONTAINING MITES ALLERGEN EXTRACT(S), AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2710544C2 |
| METHODS OF CLEANING ALLERGEN EXTRACT | 2019 |
|
RU2809823C2 |
| PYRUVAMIDE COMPOUNDS AS INHIBITORS OF ALLERGEN DUST MITES 1 GROUP, WHICH IS PEPTIDASE, AND USE THEREOF | 2011 |
|
RU2586215C2 |
